CClinicalTrials.gg
RecruitingNCT07313995DHiTPTUpdated Sep 25, 2026

Digital Health Intervention to Improve TPT Uptake

An interventional study of Digital health intervention in Tuberculosis, Pulmonary, sponsored by Arba Minch University. Recruiting at 14 sites in Ethiopia. Per ClinicalTrials.gov, last updated 2026-09-25.

Sponsored by Arba Minch University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
304
Allocation
Randomized
Sex
All
01

Study summary

Despite the evidence of the prevention and control measures of tuberculosis (TB), it still has an impact on the health, social, and economic aspects of the population. Specifically, tuberculosis in children and newly diagnosed TB cases show there is current transmission of TB; to reduce this transmission and to attain the end TB strategy, preventing household TB transmission plays a great role. However, initiation and completion of TB preventive therapy (TPT) among close contacts of index TB patients are suboptimal. Some of the identified factors of low TPT initiation and completion are insufficient patient education, inadequate understanding of TPT, health professionals' perception, parental knowledge, and belief. The digital health intervention is currently being studied as a suggested health intervention that improves the utilization of health care services, including treatment adherence. A systematic review shows that TB treatment outcomes improved with the use of patient education, counseling, text reminders, and digital health technologies. However, other literature indicates controversial results, including our systematic review result, which identified that video directly observed therapy and text message (digital intervention) have no significant effect on TPT completion. In addition, the studies are scarce; therefore, this study aims to assess the effect of video-based education intervention combined with text message reminder (digital health intervention) in improving the initiation and completion of TPT among close contacts of drug-sensitive pulmonary TB patients in South Ethiopia.

The study hypothesizes that digital health intervention for close contacts of index drug-sensitive pulmonary TB patients will lead to higher TPT initiation and completion rates than standard care.

02

Conditions studied

  • Tuberculosis, Pulmonary

Keywords

  • Digital Health
  • TB preventive therapy
  • TPT initiation
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • All household and close contacts of drug-sensitive pulmonary TB patients
  • Living in the catchment area of the selected health facility
  • Willing to stay for at least 4 months in the catchment area

Exclusion criteria

Exclusion Criteria:

  • Individuals with a known allergy to TPT drugs or those contraindicated for TPT drugs
  • Close contacts screened as symptomatic for TB
  • Close contacts with drug-resistant TB
  • Temporary residents staying for less than 4 months
04

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
304 participants (estimated)

Study arms

  • Experimental
    Digital health intervention

    In this arm, the participants will receive standard care and a digital health intervention, which is video-based health education through a mobile phone.

    Behavioral: Digital health intervention

  • No intervention
    Control

    In this arm, the participants will receive standard of care based on the national TB and TB/HIV guidelines.

Interventions

  • BehavioralDigital health intervention

    The treatment arm will provide a digital health intervention (video-based health education) in addition to standard care. Video-based education will be provided for 5-7 minutes every week for three weeks.

05

What researchers measure

Primary outcomes

  1. TB preventive therapy initiation

    The primary outcome of this study will be the number of close contacts to index TB patients who initiated TPT (mean change of TPT initiation from the baseline)

    Time frame: It will be up to 4 months.

  2. TB preventive therapy completion

    The second primary outcome of this study will be the number of close contacts to index TB patients who completed TPT (the mean change of TPT completion in relation to baseline data)

    Time frame: It will be up to 4 months.

Secondary outcomes

  1. Contact investigations

    Close contacts of index drug-sensitive pulmonary TB patients who were identified and screened for TB (the mean change of contact investigation in relation to baseline data)

    Time frame: 16 weeks.

  2. TB prevalence

    Assess TB prevalence among household/close contacts during the study period.

    Time frame: within 8 months

06

Study locations

8 of 14 sites recruiting
  • Arba Minch General Hospital and Dilfana Primary Hospital
    Arba Minch, South Ethiopia 0021, Ethiopia
    Completed
  • Chano Health center
    Arba Minch, South Ethiopia 0021, Ethiopia
    Completed
  • Gerese Primary Hospital
    Arba Minch, South Ethiopia 0021, Ethiopia
    Completed
  • Shelle Health center
    Arba Minch, South Ethiopia 0021, Ethiopia
    Completed
  • Birbir Primary Hospital
    Birbir, South Ethiopia 0021, Ethiopia
    Completed
  • Chencha Generl Hospital
    Chencha, South Ethiopia 0021, Ethiopia
    Recruiting
  • Zadha Health center
    Chencha, South Ethiopia 0021, Ethiopia
    Recruiting
  • Bulki Health center
    Felege Neway, South Ethiopia 0021, Ethiopia
    Recruiting
  • Dombe Health center
    Felege Neway, South Ethiopia 0021, Ethiopia
    Recruiting
  • Galma Health center
    Felege Neway, South Ethiopia 0021, Ethiopia
    Recruiting
  • Lotte Health center
    Felege Neway, South Ethiopia 0021, Ethiopia
    Recruiting
  • Shefite Health center
    Felege Neway, South Ethiopia 0021, Ethiopia
    Recruiting
  • Sawla General Hospital and Sawla Health Center
    Felege Neway, South Ethiopia, Ethiopia
    Recruiting
  • Laha Primary Hospital
    Laha, South Ethiopia 0021, Ethiopia
    Completed
07

References and documents

Publications

  • Abelti E, Dememew Z, Gebreyohannes A, Alemayehu Y, Terfassa T, Janfa T, Jerene D, Suarez P, Datiko D. Community-Based Tuberculosis Preventive Treatment Among Child and Adolescent Household Contacts in Ethiopia. Trop Med Infect Dis. 2025 Apr 9;10(4):102. doi: 10.3390/tropicalmed10040102. PubMed 40278775 ↗
  • Seid G, Alemu A, Dagne B, Sinshaw W, Gumi B. Tuberculosis in household contacts of tuberculosis patients in sub-Saharan African countries: A systematic review and meta-analysis. J Clin Tuberc Other Mycobact Dis. 2022 Nov 12;29:100337. doi: 10.1016/j.jctube.2022.100337. eCollection 2022 Dec. PubMed 36425906 ↗
  • Reichler MR, Khan A, Sterling TR, Zhao H, Moran J, McAuley J, Bessler P, Mangura B; Tuberculosis Epidemiologic Studies Consortium Task Order 2 Team. Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis. J Infect Dis. 2018 Aug 14;218(6):1000-1008. doi: 10.1093/infdis/jiy265. PubMed 29767733 ↗
  • Alene KA, Python A, Weiss DJ, Elagali A, Wagaw ZA, Kumsa A, Gething PW, Clements ACA. Mapping tuberculosis prevalence in Ethiopia using geospatial meta-analysis. Int J Epidemiol. 2023 Aug 2;52(4):1124-1136. doi: 10.1093/ije/dyad052. PubMed 37164625 ↗
  • Shegaze M, Boda B, Ayele G, Gebremeskel F, Tariku B, Gultie T. Why people die of active tuberculosis in the era of effective chemotherapy in Southern Ethiopia: A qualitative study. J Clin Tuberc Other Mycobact Dis. 2022 Nov 13;29:100338. doi: 10.1016/j.jctube.2022.100338. eCollection 2022 Dec. PubMed 36405995 ↗
  • Shimeles E, Enquselassie F, Aseffa A, Tilahun M, Mekonen A, Wondimagegn G, Hailu T. Risk factors for tuberculosis: A case-control study in Addis Ababa, Ethiopia. PLoS One. 2019 Apr 2;14(4):e0214235. doi: 10.1371/journal.pone.0214235. eCollection 2019. PubMed 30939169 ↗
  • Neiderud CJ. How urbanization affects the epidemiology of emerging infectious diseases. Infect Ecol Epidemiol. 2015 Jun 24;5:27060. doi: 10.3402/iee.v5.27060. eCollection 2015. PubMed 26112265 ↗
  • Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med. 2009 Jun;68(12):2240-6. doi: 10.1016/j.socscimed.2009.03.041. Epub 2009 Apr 23. PubMed 19394122 ↗
  • WHO. Global tuberculosis report 2024 [Internet] Geneva:; 2024. Available from: https://iris.who.int/bitstream/handle/10665/379339/9789240101531-eng.pdf?sequence=1

Individual participant data

Plan to share: Undecided — It is not yet decided

08

Registry details

Key details

Study ID
NCT07313995
Lead sponsor
Arba Minch University
Responsible party
Gistane Ayele (Principal Investigator, Arba Minch University) — Principal investigator
First posted
Jan 2, 2026
Start date
May 22, 2026
Primary completion
Sep 22, 2026 (estimated)
Completion
Jan 22, 2027 (estimated)
Last update
Sep 25, 2026

Study contacts

Gistane Ayele
Contact
ayelegistane@yahoo.com
_251925347903

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion